Apiam Animal Health Ltd (ASX: AHX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Apiam Animal Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $124.05 million
P/E Ratio 21.51
Dividend Yield 2.68%
Shares Outstanding 135.58 million
Earnings per share 0.042
Dividend per share 0.02
Year To Date Return 42.48%
Earnings Yield 4.65%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Apiam Animal Health Ltd (ASX: AHX)
Latest News

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
16 Sep 2021 $0.0120 100.00% Final 22 Oct 2021
19 Mar 2021 $0.0120 100.00% Interim 23 Apr 2021
17 Sep 2020 $0.0120 100.00% Final 23 Oct 2020
20 Mar 2020 $0.0080 100.00% Interim 24 Apr 2020
19 Sep 2019 $0.0080 100.00% Final 24 Oct 2019
19 Mar 2019 $0.0080 100.00% Interim 24 Apr 2019
19 Sep 2018 $0.0080 100.00% Final 26 Oct 2018
13 Mar 2018 $0.0080 100.00% Interim 27 Apr 2018
20 Sep 2017 $0.0080 100.00% Final 27 Oct 2017
13 Mar 2017 $0.0080 100.00% Interim 27 Apr 2017

AHX ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Apiam Animal Health Ltd

Apiam Animal Health Ltd provides products and services to support the health and welfare of production and mixed animals. The company offers veterinary wholesale, warehousing, logistics, and other ancillary services. Its operating segmentsinclude Dairy and Mixed, Feedlots and Pigs.

AHX Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
07 Dec 2021 $0.90 $0.01 1.12% 421,406 $0.90 $0.90 $0.90
06 Dec 2021 $0.90 $-0.01 -1.11% 23,041 $0.91 $0.91 $0.90
03 Dec 2021 $0.90 $-0.01 -1.10% 38,180 $0.90 $0.91 $0.90
02 Dec 2021 $0.91 $0.01 1.11% 58,394 $0.91 $0.91 $0.90
01 Dec 2021 $0.90 $-0.02 -2.17% 71,081 $0.91 $0.91 $0.90
30 Nov 2021 $0.92 $0.01 1.10% 57,196 $0.93 $0.93 $0.91
29 Nov 2021 $0.91 $-0.02 -2.15% 53,437 $0.93 $0.93 $0.91
26 Nov 2021 $0.93 $0.00 0.00% 43,031 $0.95 $0.95 $0.93
25 Nov 2021 $0.93 $0.02 2.20% 35,037 $0.93 $0.94 $0.92
24 Nov 2021 $0.91 $-0.03 -3.19% 23,928 $0.94 $0.94 $0.91
23 Nov 2021 $0.94 $-0.01 -1.05% 14,122 $0.95 $0.95 $0.92
22 Nov 2021 $0.95 $0.03 3.26% 32,680 $0.94 $0.95 $0.94
19 Nov 2021 $0.92 $0.00 0.00% 38,762 $0.92 $0.94 $0.92
18 Nov 2021 $0.92 $-0.02 -2.13% 25,127 $0.94 $0.94 $0.92
17 Nov 2021 $0.94 $0.03 3.31% 22,000 $0.93 $0.94 $0.93
16 Nov 2021 $0.91 $-0.02 -2.17% 18,174 $0.94 $0.94 $0.91
15 Nov 2021 $0.92 $0.02 2.22% 32,900 $0.94 $0.95 $0.92
12 Nov 2021 $0.90 $-0.04 -4.28% 64,122 $0.93 $0.93 $0.90
11 Nov 2021 $0.94 $-0.01 -1.05% 31,600 $0.94 $0.94 $0.94
10 Nov 2021 $0.95 $-0.03 -3.06% 68,139 $0.95 $0.95 $0.92
09 Nov 2021 $0.98 $0.05 5.38% 263,227 $0.95 $0.98 $0.90

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
01 Nov 2021 Christopher Richards Buy 101 $95,963
On-market trade.
22 Oct 2021 Jan Tennent Buy 708 $693
Dividend Reinvestment Plan (DRP).
22 Oct 2021 Christopher Richards Buy 385 $377,170
Dividend Reinvestment Plan (DRP).
22 Oct 2021 Andrew Vizard Buy 2 $2,751
Dividend Reinvestment Plan (DRP). As per announcement on 26/10/2021.
22 Oct 2021 Richard (Rick) Dennis Buy 274 $268
Dividend Reinvestment Plan (DRP).
22 Oct 2021 Michael van Blommestein Buy 1 $1,299
Dividend Reinvestment Plan (DRP).
06 Sep 2021 Christopher Richards Buy 31 $30,535
On-market trade.
04 May 2021 Christopher Richards Buy 50 $45,125
On-market trade.
23 Apr 2021 Andrew Vizard Buy 3 $2,712
Dividend Reinvestment Plan (DRP). As per announcement on 23/04/2021.
23 Apr 2021 Jan Tennent Buy 843 $682
Dividend Reinvestment Plan (DRP).
23 Apr 2021 Christopher Richards Buy 451 $365,693
Dividend Reinvestment Plan (DRP).
23 Apr 2021 Christopher Richards Buy 1 $1,505
Dividend Reinvestment Plan (DRP).
23 Apr 2021 Michael van Blommestein Buy 1 $1,280
Dividend Reinvestment Plan (DRP).
23 Apr 2021 Richard (Rick) Dennis Buy 327 $264
Dividend Reinvestment Plan (DRP).
21 Apr 2021 Christopher Richards Buy 296 $252,163
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Professor Andrew Lancelot Vizard Non-Executive ChairmanNon-Executive Director Nov 2015
Prof Vizard is a Principal Fellow at the Faculty of Veterinary and Agricultural Sciences, University of Melbourne and previously Associate Prof of Veterinary Epidemiology and Director of The Mackinnon Project, a recognised leader in sheep and beef veterinary consultancy. An experienced company director, he has previously held directorships in ASX companies, statutory bodies and research organisations including Animal Health Australia, the body responsible for coordinating Australia's animal health system; Primesafe, the statutory authority responsible for regulating the production of safe meat in Victoria; and the Australian Wool Corporation. He is currently Chair of the Vizard Foundation and Executive Secretary for the Hermon Slade Foundation and the Australia & Pacific Science Foundation
Mr Richard (Rick) John Dennis Non-Executive Director Nov 2015
Mr Dennis held a number of senior roles for over 35 years with Ernst & Young (EY) and was the Managing Partner of EYs Queensland practice on two occasions from 2001-2007 and from 2014-15. Mr Dennis also held a number of executive management roles at EY, including Deputy COO and CFO for the AsiaPacific practice where he was responsible for overseeing the financial and operational integration of EYs Australian and Asian member firms. Mr Dennis is a member of Australian Super's Queensland Advisory Board, a member of the Advisory Boards of EWM Group and HLB Chessboard, and an external member of the Audit & Risk Committee of Racing Queensland. He is also a non-executive director of Open Minds and ASX-listed Motorcycle Holdings Limited and ASX-listed Cettire Limited
Mr Michael van Blommestein Non-Executive Director Nov 2015
Mr Blommestein was a Vice President and Country Manager of Australia and New Zealand for Zoetis and managed the spin-off of Zoetis from Pfizer Australia. Mr Blommestein is an experienced director in the animal health sector. He presided over Animal Medicines Australia, the peak industry body for five years and was a member of the board for nearly a decade. Mr Blommestein played an integral role in leading and overseeing the transition of Animal Health Alliance into Animal Medicines Australia and has also served on the board of Animal Health Association Japan.
Dr Christopher Irwin Richards Managing Director Mar 2015
Dr Richards is the Managing Director of ASX listed Apiam Animal Health Ltd, as well as the Australian subsidiary entities and joint venture companies, which provide veterinary services to Australian regional and rural communities. Mr Richards is also a Director of registered charity, Fur Life Foundation Ltd, which raises funds to support people in rural, regional, and remote communities Mr Richards is also a Director of Apiam Solutions LLC, a JV company based in the USA that provides product solutions to the Northern American production animal industries. Mr Richards is responsible for the strategic direction of Apiam, which has seen the develop, grow, acquire and integrate production and companion animal veterinary clinics, veterinary wholesale, logistics, laboratory and genetics services businesses since 1998 into the Apiam of today. Mr Richards is a member of Australian Pork Limited's Biosecurity Strategic Review Panel and ASF Advisory Group.
Professor Jan Tennent Non-Executive Director Aug 2018
Mr Tennent is a Fellow of the Australian Academy of Technology and Engineering and the Australian Society for Microbiology and, a Principal Fellow at the University of Melbourne. She is an internationally recognised researcher with specialist knowledge of antimicrobial resistance mechanisms and the discovery and commercialisation of vaccines. Mr Tennent has held senior roles at CSIRO, CSL, and Pfizer Animal Health where she was the Director of Business Development and Global Alliances in the APAC region. Her most recent executive management role was CEO of Biomedical Research Victoria (2012-2019). Mr Tennent is also a non-executive director of AusBiotech Limited and eviDent Foundation Limited.
Ms Eryl Baron Company Secretary Nov 2020
-
Matthew White Chief Financial Officer
-
Brian Scutt Chief Operating Officer
-
Eryl Baron Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Cjoea Family Company Pty Ltd <Richards Familya/C> 30,219,451 22.60%
Petstock Investments Pty Ltd 21,240,500 15.88%
Citicorp Nominees Pty Limited 5,852,675 4.38%
Cs Third Nominees Pty Limited <HSBC Cust Nom Au Ltd 13 A/C> 3,008,926 2.25%
Scolexia Commodity Pty Ltd 2,755,777 2.06%
Donald Crosby & Sharron Crosby <D & S Crosby Family A/C> 2,207,506 1.65%
Certane Ct Pty Ltd <Apiam Animal Est Unallo Ac> 2,139,938 1.60%
Cobash Pty Limited <J & S Wright Family A/C> 1,872,006 1.40%
Hamilton Animal Health Pty Ltd 1,564,270 1.17%
HSBC Custody Nominees (Australia) Limited 1,409,907 1.05%
Four Post Investments Pty Ltd <Johnstone Investment A/C> 1,386,700 1.04%
Mr Lincoln O'Meara 1,377,888 1.03%
Aileen Mary Vanderfeen 1,377,888 1.03%
Rachel Louise O'Meara 1,377,888 1.03%
Mr Roger Charles Carmody & Mrs Maris Moore Carmody <R & M Carmody A/C> 1,258,650 0.94%
Mrs Kate Judith Malin <Howison Family A/C> 1,229,161 0.92%
Sonjaswright Pty Limited 1,211,846 0.91%
David Frith Pty Ltd <Frith Family A/C> 1,104,909 0.83%
Mr Neil Leighton & Mrs Helen Leighton <Leighton Super Fund A/C> 1,104,131 0.83%
Cindy Jane Pty Ltd <Cindy Jane Family A/C> 1,045,701 0.78%

Profile

since

Note